Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Chemosphere

Volumn 52, Issue 4, 2003, Pages 655-662

  Doi, Hirotoshi ^a,b   Baba, Tadashi ^b   Tohyama, Chiharu ^a,c   Nohara, Keiko ^a,c  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

B cell; CytochromCYP1A1; T cell; TCDD

Indexed keywords

CLONING; GENES; IMMUNOLOGY;

FUNCTIONAL ACTIVATION;

AROMATIC HYDROCARBONS;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; XENOBIOTIC AGENT;

POLLUTION EXPOSURE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; CYP1A1 GENE; DNA RESPONSIVE ELEMENT; ENHANCER REGION; FEMALE; GENE; GENE EXPRESSION; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE;

EID: 0037643646     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-6535(03)00112-7     Document Type: Article

References (43)

1. Berghard, A., Gradin, K., Pongratz, I., Whitelaw, M., Poelinger, L., 1993. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome p-4501A1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13, 677-689.
2. Birnbaum, L.S., Tuomisto, J., 2000. Non-carcinogenic effects of TCDD in animals. Food Addit. Contam. 17, 275-288.
3. Davarinos, N.A., Pollenz, R.S., 1999. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytoplasmic proteasome following nuclear export. J. Biol. Chem. 274, 28708-28715.
4. De Krey, G.K., Kerkvliet, N.I., 1995. Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation. Toxicology 97, 105-112.
5. Dey, A., Parmar, D., Dayal, M., Dhawan, A., Seth, P.K., 2001. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes. Evidence for catalytic activity and mRNA expression. Life Sci. 69, 383-393.
6. Fujimaki, H., Nohara, K., Kobayashi, T., Suzuki, K., Eguchi-Kasai, K., Tsukumo, S., Kijima, M., Tohyama, C., 2002. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice. Toxicol. Sci. 66, 117-124.
7. Gehrs, B.C., Smialowicz, R.J., 1999. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 134, 79-88.
8. Germolec, D.R., Henry, E.C., Maronpot, R., Foley, J.F., Adams, N.H., Gasiewicz, T.A., Luster, M.I., 1996. Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD). Toxicol. Appl. Pharmacol. 137, 57-66.
9. Giannone, J.V., Li, W., Probst, M., Okey, A.B., 1998. Prolonged depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 55, 489-497.
10. Hanson, C.D., Smialowicz, R.J., 1994. Evaluation of the effect of low-level 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on cell mediated immunity. Toxicology 88, 213-224.
11. Hayashi, S., Okabe-Kado, J., Honma, Y., Kawajiri, K., 1995. Expression of Ah receptor (TCDD receptor) during human monocytic differentiation. Carcinogenesis 16, 1403-1409.
12. Holsapple, M.P., Snyder, N.K., Wood, S.C., Morris, D.L., 1991. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology 69, 219-255.
13. Ito, T., Inouye, K., Fujimaki, H., Tohyama, C., Nohara, K., 2002. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol. Sci. 70, 46-54.
14. Ke, S., Rabson, A.B., Germino, J.F., Gallo, M.A., Tian, Y., 2001. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-α and lipopolysaccharide. J. Biol. Chem. 276, 39638-39644.
15. Kerkvliet, N.I., 2002. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2, 277-291.
16. Kerkvliet, N.I., Brauner, J.A., 1987. Mechanisms of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD)-induced humoral immune suppression: evidence of primary defect in T-cell regulation. Toxicol. Appl. Pharmacol. 87, 18-31.
17. Kobayashi, A., Numayama-Tsuruta, K., Sogawa, K., Fujii-Kuriyama, Y., 1997. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. 122, 703-710.
18. Lang, D.S., Becker, S., Clark, G.C., Devlin, R.B., Koren, H.S., 1994. Lack of direct immunosuppressive effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch. Toxicol. 68, 296-302.
19. Lawrence, B.P., Leid, M., Kerkvliet, N.I., 1996. Distribution and behavior of the Ah receptor in murine T lymphocytes. Toxicol. Appl. Pharmacol. 138, 275-284.
20. Lundberg, K., Dencker, L., Gronvik, K.O., 1992. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice. Int. J. Immunopharmacol. 14, 699-705.
21. Ma, Q., 2001. Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles. Curr Drug Metab. 2, 149-164.
22. Masten, S.A., Shiverick, K.T., 1996. Characterization of the aryl hydrocarbon receptor complex in human B lymphocytes: evidence for a distinct nuclear DNA-binding form. Arch. Biochem. Biophys. 336, 297-308.
23. Nohara, K., Ozawa, H., Tai, T., Saji, H., Fujimaki, H., 1997. Gangliosides involved in activation of rat T lineage cells. Biochim. Biophys. Acta 1345, 207-214.
24. Nohara, K., Ushio, H., Tsukumo, S., Kobayashi, T., Kijima, M., Tohyama, C., Fujimaki, H., 2000a. Alteration of thymocyte development, thymic emigrants and peripheral T cell population in rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 145, 227-235.
25. Nohara, K., Fujimaki, H., Tsukumo, S., Ushio, H., Miyabara, Y., Kijima, M., Tohyama, C., Yonemoto, J., 2000b. The effects of perinatal exposure to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune organs in rats. Toxicology 154, 123-133.
26. Nohara, K., Fujimaki, H., Tsukumo, S., Inouye, K., Sone, H., Tohyama, C., 2002. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57B1/6 mice. Toxicology 172, 49-58.
27. Park, S., Henry, E.C., Gasiewicz, T.A., 2000. Regulation of DNA binding activity of the ligand-activated aryl hydro-carbon receptor by tyrosine phosphorylation. Arch. Biochem. Biophys. 381, 302-312.
28. Riddick, D.S., Huang, Y., Harper, P.A., Okey, A.B., 1994. 2,3,7,8-Tetrachlorodibenezo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1. J. Biol. Chem. 269, 12118-12128.
29. Salomon-Nguyen, F., Della-Valle, V., Mauchauffe, M., Coniat, M.B., Ghysdael, J., Berger, R., Bernard, O.A., 2000. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. In: Proc. Natl. Acad. Sci. USA 97, pp. 6757-6762.
30. Schmidt, J.V., Bradfield, C.A., 1996. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55-89.
31. + T cells in adoptively transferred mice. Toxicol. Sci. 56, 340-350.
32. Smialowicz, R.J., Riddle, M.M., Williams, W.C., Diliberto, J.J., 1994. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats. Toxicol. Appl. Pharmacol. 124, 248-256.
33. Staples, J.E., Murante, F.G., Fiore, N.C., Gasiewicz, T.A., Silverstone, A.E., 1998. Thymic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are strictly dependent on aryl hydrocarbon receptor activation in hemopoietic cells. J. Immunol. 160, 3844-3854.
34. Stephen, F.D., Drahushuk, A.T., Olson, J.R., 1997. Cytochrome P450 1A1 induction in rat lymphoid tissues following in vivo and in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin requires protein kinase C. Toxicology 124, 39-51.
35. Sulentic, C.E.W., Holsapple, M.P., Kaminski, N.E., 2000. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J. Pharmacol. Exp. Ther. 295, 705-716.
36. Tohyama, C., 2002. Low-dose exposure to dioxin, its toxicities and health risk assessment. Environ. Sci. 9, 37-50.
37. Tomar, R.S., Kerkvliet, N.I., 1991. Reduced T-helper cell function in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Lett. 57, 55-64.
38. Vanden Heuvel, J.P., Clark, G.C., Thompson, C.L., McCoy, Z., Miller, C.R., Lucier, G.W., Bell, D.A., 1993. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14, 2003-2006.
39. Vorderstrasse, B.A., Steppan, L.B., Silverstone, A.E., Kerkvliet, N.I., 2001. Aryl hydrocarbon receptor-deficient mice generated normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol. Appl. Pharmacol. 171, 157-164.
40. Vos, J.G., Heer, C., Loveren, H., 1997/98. Immunotoxic effects of TCDD and toxic equivalency factors. Teratogenesis Carcinog. Mutagen. 17, 275-284.
41. Waithe, W.I., Michaud, M., Harper, P.A., Okey, A.B., Anderson, A., 1991. The AhR receptor, cytochrome P4501A1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharmacol. 41, 85-92.
42. Williams, C.E., Crawford, R.B., Holsapple, M.P., Kaminski, N.E., 1996. Identification of functional aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator in murine splenocytes. Biochem. Pharmacol. 52, 771-780.
43. Wilson, C.L., Safe, S., 1998. Mechanism of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 26, 657-671.